Contrast-Enhanced Spectral Mammography (CESM)

NCT06311695 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 263

Last updated 2024-06-24

No results posted yet for this study

Summary

The study's objective is to compare the diagnostic accuracy of the contrast-enhanced mammography (CEM) , considering as reference the classification obtained with Vacuum Assisted Breast Biopsy (VABB).

Conditions

Interventions

DEVICE

Contrast Enhanced Mammography

Contrast Enhanced Mammography

Sponsors & Collaborators

  • European Institute of Oncology

    lead OTHER

Principal Investigators

  • Enrico Cassano, MD · European Institute of Oncology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-16
Primary Completion
2025-02-28
Completion
2025-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06311695 on ClinicalTrials.gov